July 8, 2006 |
An administrative law judge has allowed drug maker Roche Holding Ltd. to continue to import an experimental anemia drug at the center of a patent fight between Roche and Amgen Inc., the companies said Friday. The judge at the U.S. International Trade Commission has determined that Roche can import its experimental drug peg-EPO, also known as Cera, under an exception for clinical trials, the companies said.
November 17, 2006 |
A study linking higher doses of a Johnson & Johnson anemia drug to heart risk prompted a U.S. lawmaker to renew questions about Medicare's policy on Amgen Inc.'s identical medicine. The Medicare plan for the elderly and disabled, including people with failed kidneys, is buying excess doses of the erythropoietin anemia drug, Rep. Bill Thomas (R-Bakersfield), chairman of the House Ways and Means Committee, said in a letter Wednesday.
February 4, 1989 |
Amgen Inc., a Thousand Oaks biotechnology company already embroiled in patent lawsuits over its new anti-anemia drug, has been hit with another suit from its own marketing partner, consumer products giant Johnson & Johnson. Ortho Pharmaceutical, a Johnson & Johnson unit, asked a federal court in Delaware to block Amgen's effort to get federal approval for the drug and to begin marketing it.
August 2, 1994 |
Drug maker Carter-Wallace Inc. told doctors Monday to take their patients off the epilepsy drug Felbatol after two people who took it died from a serious form of anemia, a development that led to the company's stock losing a third of its value. The Food and Drug Administration and the company said 10 patients contracted a rare and frequently fatal affliction called aplastic anemia, in which the bone marrow stops making blood cells.
April 8, 1998 |
The National Academy of Sciences recommended for the first time Tuesday that large segments of the population take vitamins. All women of childbearing age should take a daily folic acid supplement to cut the risk of serious birth defects, and all older adults should take daily vitamin B12 supplements to guard against anemia, the academy recommended.
April 21, 2000 |
A widely used new blood thinner that is routinely given to heart patients after angioplasty appears in rare cases to trigger a deadly blood disease. The drug, called clopidogrel (trade named Plavix) prevents blood clots and has been taken by more than 3 million people worldwide since its introduction two years ago. For the first time, doctors have linked the medicine to thrombotic thrombocytopenic purpura, or TTP, a dangerous form of anemia.
CALIFORNIA | LOCAL
July 12, 1994 |
For thousands of people across the country with leukemia and other blood diseases, the chance of finding a life-saving bone marrow donor can be as little as one in 100. But for 17-year-old Lisa Mederos, the odds are closer to one in a million. It's not Mederos' illness--a potentially fatal type of anemia--that makes her chances so slim. It's her ethnicity.
June 25, 1998 |
Shares of Amgen Inc., the world's largest biotechnology company, rose 6.5% as the government confirmed that Medicare will pay for the company's anemia treatment Epogen even if the drug boosts red blood cells over an earlier limit. Amgen's stock rose $4.06 to close at $66.75 in Nasdaq trading. The shares earlier hit a 52-week high of $67.25. Thousand Oaks-based Amgen could sell more Epogen because the federal government changed a 1997 rule on Medicare reimbursement for the drug.
CALIFORNIA | LOCAL
April 1, 1995 |
If enough people take a simple 15-minute blood test, Valerie Sun may be able to live a normal life. All day today, Valerie will be watching anxiously as potential donors line up on the Thousand Oaks High School campus for a screening test to see if their bone marrow matches that of the 13-year-old girl. Valerie has aplastic anemia, an often-fatal blood disease.
CALIFORNIA | LOCAL
February 11, 1999
With only a few exceptions, transfusions should not be given to critically ill patients--especially relatively young ones--until they are severely anemic, Canadian researchers report in today's New England Journal of Medicine. For reasons that are not yet clear, giving blood to patients who are only mildly anemic makes them more likely to die, the researchers found. The exceptions are patients who are bleeding or suffering from heart attacks, cardiovascular disease or emphysema.